|
Leadership on partnerships and technical network management for the Abortion Service Quality (ASQ) Initiative |
Dominic Montagu, DrPH |
Ethiopia, Nigeria, Bangladesh, Argentina |
|
|
|
Open Tibia Research Project |
Theodore Miclau, MD |
Costa Rica, Mexico, Nicaragua, Panama, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Paraguay, Peru, Uruguay, Venezuela, Cuba |
|
|
|
NICHD International & Domestic Pediatric & Maternal HIV Studies Coordinating Center |
Theodore Ruel, MD |
Kenya, Tanzania, Thailand, Argentina, Brazil |
|
|
|
Systematic reviews to support the Antiretroviral Therapy (ART) Consolidated Guidelines - 2014/HTM/HIV/007 |
George Rutherford, MD |
Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Botswana, Lesotho, Namibia, South Africa, Swaziland, Western Africa, Benin, Burkina Faso, Ivory Coast, Gambia, Ghana, Liberia, Mali, Mauritania, Niger, Nigeria, Sierra Leone, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, China, South Korea, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Pakistan, Sri Lanka, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Singapore, Thailand, Timor-Leste, Philippines, Armenia, Georgia, Iraq, Israel, Jordan, Kuwait, Saudi Arabia, Syria, Turkey, United Arab Emirates, Yemen, Bosnia and Herzegovina, Bulgaria, Croatia, Macedonia, Moldova, Slovenia, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, French Guiana, Paraguay, Peru, Uruguay, Venezuela, Turks and Caicos Islands, Antigua and Barbuda, Aruba, Bahamas, Barbados, Cayman Islands, Dominica, Dominican Republic, Haiti, Jamaica, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Trinidad and Tobago, American Samoa, Northern Mariana Islands, Guam, Fiji, Marshall Islands, Micronesia, Palau, Papua New Guinea, Samoa, Solomon Islands, Vanuatu |
|
|
|
Child Family Health International (CFHI) |
Jessica Evert, MD |
Uganda, Tanzania, South Africa, Ghana, India, Philippines, Mexico, Argentina, Bolivia, Ecuador |
|
|
|
Creating an Evidence Base to Limit Sugar Sweetened Beverage Consumption in Argentina |
Alicia Fernandez, MD |
Argentina |
|
|
|
Global Brain Health Institute |
Victor Valcour, MD, PhD |
South Africa, Viet Nam, Turkey, Greece, Mexico, Argentina, Brazil, Cuba, Dominican Republic |
|
|
|
Interventions for Improving Retention in Antiretroviral Therapy (ART) Programs (PO 200988865) |
George Rutherford, MD |
Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Western Sahara, Botswana, Lesotho, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Cape Verde, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Togo, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Pakistan, Sri Lanka, Brunei, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Thailand, Timor-Leste, Philippines, Armenia, Azerbaijan, Georgia, Iraq, Jordan, Lebanon, Syria, Turkey, Yemen, Albania, Bosnia and Herzegovina, Bulgaria, Croatia, Montenegro, Slovakia, Slovenia, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Argentina, Bolivia, Brazil, Ecuador, Peru, Uruguay, Venezuela, Haiti, Jamaica |
|
|
|
LOC-IMPAACT Leadership Group |
Theodore Ruel, MD |
Malawi, Uganda, Tanzania, Zambia, Zimbabwe, Botswana, South Africa, China, India, Thailand, Argentina, Brazil |
|
|
|
International Maternal Pediatric Adolescent AIDS Clinical Trial Group Master Member Agreement |
|
Malawi, Uganda, Tanzania, Zambia, Zimbabwe, Botswana, South Africa, China, India, Thailand, Argentina, Brazil, Bahamas |
|
|
|
Oral HIV/AIDS Research Alliance |
Caroline Shiboski, DDS, MPH, PhD |
Uganda, Zimbabwe, Botswana, South Africa, India, Argentina |
|
|
|
Pegylated Interferon Lambda w/wo Daclatasvir, Compared to Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C Genotype 2 and 3 |
Mandana Khalili, MD |
South Korea, Japan, India, Singapore, Belgium, Finland, France, Greece, Italy, Netherlands, Russia, United Kingdom, Mexico, Argentina, Brazil, Chile, Canada, Australia, New Zealand |
|
|
|
ENROLL-HD -A Prospective Registry Study in a Global Huntington's Disease Cohort |
Michael Geschwind, MD, PhD |
Argentina, Chile, Australia |
|
|
|
WHO Adolescent HTC Review Update (PO# 200660799) |
George Rutherford, MD |
Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Western Sahara, Botswana, Lesotho, Namibia, South Africa, Swaziland, Western Africa, Benin, Burkina Faso, Cape Verde, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Togo, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, China, Hong Kong S.A.R., China, North Korea, Japan, Macao S.A.R., China, Mongolia, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Pakistan, Sri Lanka, Brunei, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Singapore, Thailand, Timor-Leste, Philippines, Armenia, Azerbaijan, Bahrain, Cyprus, Georgia, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Palestinian Territory, Qatar, Saudi Arabia, Syria, Turkey, United Arab Emirates, Yemen, Albania, Andorra, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Jersey, Kosovo, Latvia, Liechtenstein, Lithuania, Luxembourg, Macedonia, Malta, Moldova, Monaco, Montenegro, Netherlands, Norway, Poland, Portugal, Romania, Russia, San Marino, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Ukraine, United Kingdom, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela, Anguilla, Turks and Caicos Islands, Antigua and Barbuda, Aruba, Bahamas, Barbados, Cayman Islands, Cuba, Dominica, Dominican Republic, Grenada, Guadeloupe, Haiti, Jamaica, Martinique, Puerto Rico, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Trinidad and Tobago, Bermuda, Canada, Greenland, U.S. Virgin Islands, American Samoa, Northern Mariana Islands, Australia, Cook Islands, Guam, French Polynesia, Fiji, Kiribati, Marshall Islands, Micronesia, Nauru, New Zealand, Niue, Palau, Papua New Guinea, Samoa, Solomon Islands, Tokelau, Tonga, Tuvalu, Vanuatu |
|
|
|
A Phase 2, Open-Label Study of Daclatasvir (BMS-790052) and TMC435 in Combination With or Without Ribavirin (RBV) For Treatment-Naive Subjects or Null Responders to Prior Peginterferon Alfa (PegIFN)/RBV Therapy with Genotype 1 Chronic Hepatitis C |
Anne Luetkemeyer, MD |
France, Germany, Hungary, Spain, Argentina |
|
|
|
Comparative Effectiveness of Policies to Reduce Dietary Salt Intake in the Pacific Rim |
Kirsten Bibbins-Domingo, MD, PhD |
China, Mexico, Argentina, Chile |
|
|
|
International Maternal Pediatric Adolescent AIDS Clinical Trials Group Leadership Award |
|
Argentina, Brazil |
|
|
|
Study of BMS-790052 plus Peg-Interferon alfa 2a and Ribavirin in Previously Untreated HCV Patients Coinfected with HIV and HCV |
Anne Luetkemeyer, MD |
France, Germany, Italy, Russia, Spain, United Kingdom, Argentina, Puerto Rico, Canada, Australia |
|
|
|
Genome wide association study of breast cancer subtype and survival in Latinas |
Laura Fejerman, PhD |
Argentina, United States |
|
|
|
Comparative Effectiveness Analysis of Treat-to-Target and Risk-Based Blood Pressure Control Guidelines |
Kirsten Bibbins-Domingo, MD, PhD |
Argentina, Chile |
|
|
|
Prices and Affordability of Essential Medicines across Pacific Latin America during Economic Crisis |
Leslie Wilson, PhD, MS |
Argentina, Ecuador |
|
|
|
International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) |
|
Argentina, Brazil |
|
|
|
International Research Registry Network for Sjögren Syndrome |
Caroline Shiboski, DDS, MPH, PhD |
China, Japan, India, Denmark, United Kingdom, Argentina |
|
|
|
Assess Clonidine and Aspirin in Noncardiac Surgery Patients at Risk of Perioperative Cardiovascular Event |
|
South Africa, China, India, Pakistan, Malaysia, Austria, Belgium, Denmark, France, Germany, Italy, Spain, Switzerland, United Kingdom, Argentina, Brazil, Chile, Colombia, Peru, Canada, Australia |
|
|
|
Replication, Pathogenesis and Evolution of RNA Viruses, Including Dengue |
Raul Andino-Pavlovsky, PhD |
Argentina |
|
|
|
Global Health Sciences Clinical Scholars Program Immersion Experience |
Christopher Stewart, MD |
Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Botswana, Lesotho, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Cape Verde, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Togo, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, China, North Korea, Mongolia, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Pakistan, Sri Lanka, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Thailand, Timor-Leste, Philippines, Armenia, Azerbaijan, Georgia, Iraq, Israel, Jordan, Lebanon, Palestinian Territory, Syria, Turkey, Yemen, Albania, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Kosovo, Latvia, Lithuania, Macedonia, Moldova, Montenegro, Romania, Russia, Serbia, Ukraine, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela, Antigua and Barbuda, Cuba, Dominica, Dominican Republic, Grenada, Haiti, Jamaica, Saint Lucia, Saint Vincent and the Grenadines, American Samoa, Fiji, Kiribati, Marshall Islands, Micronesia, Palau, Papua New Guinea, Samoa, Solomon Islands, Tonga, Tuvalu, Vanuatu |
|
|
|
BMS-790052 with Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Genotype 1 Infected Subjects Who are Null or Partial Responders to Peginterferon Alfa plus |
Mandana Khalili, MD |
Mexico, Argentina, Puerto Rico, Australia |
|
|
|
University of California Global Health Institute Women's Health and Empowerment Center of Expertise Post-Doctoral Fellowship Program |
Craig Cohen, MD, MPH |
Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Botswana, Lesotho, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Cape Verde, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Togo, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, China, North Korea, South Korea, Mongolia, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Pakistan, Sri Lanka, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Thailand, Timor-Leste, Philippines, Armenia, Azerbaijan, Georgia, Iraq, Jordan, Lebanon, Palestinian Territory, Syria, Turkey, Yemen, Albania, Belarus, Bosnia and Herzegovina, Bulgaria, Kosovo, Latvia, Lithuania, Macedonia, Moldova, Montenegro, Romania, Russia, Serbia, Ukraine, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela, Antigua and Barbuda, Cuba, Dominica, Grenada, Haiti, Jamaica, Saint Lucia, Saint Vincent and the Grenadines, American Samoa, Fiji, Kiribati, Marshall Islands, Micronesia, Palau, Papua New Guinea, Samoa, Solomon Islands, Tonga, Tuvalu, Vanuatu |
|
|
|
Epigenetic Profiling of Multiple Cell and Tissue Types in Sjögren's Syndrome |
|
China, Japan, India, Denmark, United Kingdom, Argentina |
|
|
|
VIPS: Vascular Effects of Infection in Pediatric Stroke |
Heather Fullerton, MD |
China, Malaysia, Argentina, Chile, Australia |
|
|
|
Research Training in International Transfusion Safety |
Edward Murphy, MD, MPH |
South Africa, France, Honduras, Mexico, Argentina, Brazil |
|
|
|
CAPS/Fogarty Visiting Scientists and In-Country Research Training Activities |
George Rutherford, MD |
Ethiopia, Kenya, Rwanda, Uganda, Tanzania, Zambia, Zimbabwe, Egypt, Sudan, South Africa, Burkina Faso, Ghana, Nigeria, Senegal, Kazakhstan, China, Japan, India, Iran, Nepal, Cambodia, Indonesia, Viet Nam, Thailand, Philippines, Georgia, Jordan, Croatia, Czech Republic, Russia, Costa Rica, Guatemala, Mexico, Argentina, Brazil, Chile, Ecuador, Peru, Venezuela, Dominican Republic, Puerto Rico, Trinidad and Tobago, Canada |
|
|
|
Hemophilia Inhibitor Genetics Study |
James Huang, MD |
South Africa, Argentina, Colombia, Venezuela |
|
|
|
Congenital Syphilis Elimination Cost-Effectiveness Analysis |
James Kahn, MD, MPH |
Burundi, Comoros, Djibouti, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Tanzania, Zambia, Zimbabwe, Cameroon, Central African Republic, Chad, Congo (Brazzaville), Gabon, Sao Tome and Principe, Sudan, Tunisia, Botswana, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Ivory Coast, Ghana, Guinea, Mali, Nigeria, Sierra Leone, Togo, Kazakhstan, Kyrgyzstan, Uzbekistan, China, Mongolia, Afghanistan, Bangladesh, India, Maldives, Nepal, Sri Lanka, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Thailand, Philippines, Jordan, Oman, Saudi Arabia, Belarus, Czech Republic, Estonia, Germany, Hungary, Lithuania, Macedonia, Moldova, Romania, United Kingdom, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Panama, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Guyana, Paraguay, Peru, Uruguay, Antigua and Barbuda, Cuba, Dominica, Dominican Republic, Grenada, Trinidad and Tobago, Fiji, Kiribati, Papua New Guinea |
|
|
|
AIDS Policy Research Center |
Stephen Morin, PhD |
Tanzania, Zimbabwe, South Africa, Kazakhstan, China, Japan, India, Cambodia, Viet Nam, Thailand, Philippines, Croatia, South America, Argentina, Brazil, Peru, Antigua and Barbuda, Barbados, Saint Kitts and Nevis, Saint Vincent and the Grenadines |
|
|
|
NICHD International and Domestic Pediatric and Maternal HIV Studies Coordinating Center |
Diane Wara, MD |
Argentina, Brazil |
|
|
|
Tobacco Control and Research and Training in South America |
Eliseo Perez-Stable, MD |
Argentina |
|
|
|
Master Agreement: International Network for Strategic Initiatives in Global HIV Trials/ICR INSIGHT |
Steven Deeks, MD |
Uganda, South Africa, Mali, Nigeria, China, Malaysia, Thailand, Mexico, Argentina, Brazil, Chile, Peru, Uruguay |
|
|
|
Center for AIDS Prevention Studies |
Stephen Morin, PhD |
Kenya, Uganda, Tanzania, Zambia, Zimbabwe, South Africa, China, India, Iran, Nepal, Cambodia, Viet Nam, Myanmar, Thailand, Argentina, Peru |
|
|
|
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) |
Steven Deeks, MD |
Tanzania, Zambia, Morocco, South Africa, Mali, Thailand, Greece, Argentina, Brazil, Chile, Peru |
|
|
|
San Francisco National Clinical Trial Center, ESPIRIT |
Steven Deeks, MD |
Morocco, Japan, Singapore, Thailand, Israel, Austria, Belgium, Denmark, France, Germany, Ireland, Italy, Netherlands, Norway, Poland, Portugal, Spain, United Kingdom, Argentina, Brazil, Canada, Australia |
|
|
|
International AIDS Training Program |
|
Kenya, Uganda, Tanzania, South Africa, Bangladesh, India, Argentina, Chile |
|
|
|
International AIDS Education and Training Center |
E. Michael Reyes, MD, MPH |
Ethiopia, Kenya, Madagascar, Malawi, Mozambique, Rwanda, Somalia, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Gabon, Egypt, Morocco, Sudan, Tunisia, Botswana, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Ivory Coast, Gambia, Ghana, Guinea-Bissau, Mali, Niger, Nigeria, Senegal, Togo, Kyrgyzstan, China, Bangladesh, India, Iran, Nepal, Pakistan, Sri Lanka, Cambodia, Indonesia, Viet Nam, Laos, Myanmar, Singapore, Thailand, Timor-Leste, Philippines, Georgia, Iraq, Lebanon, Yemen, Czech Republic, Estonia, Greece, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Guyana, Paraguay, Peru, Venezuela, Antigua and Barbuda, Bahamas, Barbados, Dominica, Dominican Republic, Grenada, Haiti, Jamaica, Puerto Rico, Trinidad and Tobago, Australia |
|
|
|
International Research Registry Network for Sjogren's Syndrome |
Caroline Shiboski, DDS, MPH, PhD |
China, Japan, India, Denmark, United Kingdom, Argentina |
|
|
|
Tobacco Use Among Argentinean Youth: A Cohort Study |
Eliseo Perez-Stable, MD |
Argentina |
|
|